[Secondary malignant lymphedema in head and neck tumors].
Identifieur interne : 006830 ( Main/Exploration ); précédent : 006829; suivant : 006831[Secondary malignant lymphedema in head and neck tumors].
Auteurs : Bernhard Hammerl [Autriche] ; Walter DöllerSource :
- Wiener medizinische Wochenschrift (1946) [ 0043-5341 ] ; 2008.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antinéoplasiques (usage thérapeutique), Association thérapeutique, Diagnostic différentiel, Humains, Lymphoedème (), Lymphoedème (étiologie), Mâle, Octréotide (usage thérapeutique), Récidive tumorale locale (), Soins palliatifs, Sélénium (usage thérapeutique), Techniques de physiothérapie, Tumeurs de l'oropharynx (), Tumeurs oto-rhino-laryngologiques (), Évolution de la maladie.
- MESH :
- usage thérapeutique : Antinéoplasiques, Octréotide, Sélénium.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Association thérapeutique, Diagnostic différentiel, Humains, Lymphoedème, Mâle, Récidive tumorale locale, Soins palliatifs, Techniques de physiothérapie, Tumeurs de l'oropharynx, Tumeurs oto-rhino-laryngologiques, Évolution de la maladie.
English descriptors
- KwdEn :
- Antineoplastic Agents (therapeutic use), Combined Modality Therapy, Diagnosis, Differential, Disease Progression, Humans, Lymphedema (etiology), Lymphedema (therapy), Male, Middle Aged, Neoplasm Recurrence, Local (therapy), Octreotide (therapeutic use), Oropharyngeal Neoplasms (therapy), Otorhinolaryngologic Neoplasms (therapy), Palliative Care, Physical Therapy Modalities, Selenium (therapeutic use).
- MESH :
- chemical , therapeutic use : Antineoplastic Agents, Octreotide, Selenium.
- etiology : Lymphedema.
- therapy : Lymphedema, Neoplasm Recurrence, Local, Oropharyngeal Neoplasms, Otorhinolaryngologic Neoplasms.
- Combined Modality Therapy, Diagnosis, Differential, Disease Progression, Humans, Male, Middle Aged, Palliative Care, Physical Therapy Modalities.
Abstract
The occurrence of edema is a serious problem of patients suffering from cancer and may have various causes. Particularly, the secondary malignant lymphedema poses a special threat to patients. In some cases, it indicates the progression of illness, and in fact also results in mutilating physical changes, which add to the already existing impairments caused by the cancer disease. So far therapeutic interventions are limited. Current management consists of physical therapy and pharmacological interventions. There are few powerful studies concerning the efficiency and hardly any concerning combined or comparative treatment in the literature. Most of them focus on the management of lymphedema in breast cancer patients. Preventive measures and supportive therapy are rarely being discussed. In this case report, we describe the successful use of Selen and Sandostatin in treating a facial edema of a patient with advanced head-neck cancer.
DOI: 10.1007/s10354-008-0629-5
PubMed: 19165449
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002F96
- to stream PubMed, to step Curation: 002F96
- to stream PubMed, to step Checkpoint: 002F96
- to stream Ncbi, to step Merge: 003178
- to stream Ncbi, to step Curation: 003178
- to stream Ncbi, to step Checkpoint: 003178
- to stream Main, to step Merge: 006920
- to stream Main, to step Curation: 006830
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Secondary malignant lymphedema in head and neck tumors].</title>
<author><name sortKey="Hammerl, Bernhard" sort="Hammerl, Bernhard" uniqKey="Hammerl B" first="Bernhard" last="Hammerl">Bernhard Hammerl</name>
<affiliation wicri:level="3"><nlm:affiliation>Station für Palliativmedizin, 5. Medizinische Abteilung mit Onkologie, Krankenhaus Hietzing, Wien, Osterreich. bernhard.hammerl@wienkav.at</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Autriche</country>
<wicri:regionArea>Station für Palliativmedizin, 5. Medizinische Abteilung mit Onkologie, Krankenhaus Hietzing, Wien</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doller, Walter" sort="Doller, Walter" uniqKey="Doller W" first="Walter" last="Döller">Walter Döller</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:19165449</idno>
<idno type="pmid">19165449</idno>
<idno type="doi">10.1007/s10354-008-0629-5</idno>
<idno type="wicri:Area/PubMed/Corpus">002F96</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002F96</idno>
<idno type="wicri:Area/PubMed/Curation">002F96</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F96</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F96</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002F96</idno>
<idno type="wicri:Area/Ncbi/Merge">003178</idno>
<idno type="wicri:Area/Ncbi/Curation">003178</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003178</idno>
<idno type="wicri:doubleKey">0043-5341:2008:Hammerl B:secondary:malignant:lymphedema</idno>
<idno type="wicri:Area/Main/Merge">006920</idno>
<idno type="wicri:Area/Main/Curation">006830</idno>
<idno type="wicri:Area/Main/Exploration">006830</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Secondary malignant lymphedema in head and neck tumors].</title>
<author><name sortKey="Hammerl, Bernhard" sort="Hammerl, Bernhard" uniqKey="Hammerl B" first="Bernhard" last="Hammerl">Bernhard Hammerl</name>
<affiliation wicri:level="3"><nlm:affiliation>Station für Palliativmedizin, 5. Medizinische Abteilung mit Onkologie, Krankenhaus Hietzing, Wien, Osterreich. bernhard.hammerl@wienkav.at</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Autriche</country>
<wicri:regionArea>Station für Palliativmedizin, 5. Medizinische Abteilung mit Onkologie, Krankenhaus Hietzing, Wien</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Doller, Walter" sort="Doller, Walter" uniqKey="Doller W" first="Walter" last="Döller">Walter Döller</name>
</author>
</analytic>
<series><title level="j">Wiener medizinische Wochenschrift (1946)</title>
<idno type="ISSN">0043-5341</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (therapeutic use)</term>
<term>Combined Modality Therapy</term>
<term>Diagnosis, Differential</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (therapy)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local (therapy)</term>
<term>Octreotide (therapeutic use)</term>
<term>Oropharyngeal Neoplasms (therapy)</term>
<term>Otorhinolaryngologic Neoplasms (therapy)</term>
<term>Palliative Care</term>
<term>Physical Therapy Modalities</term>
<term>Selenium (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Antinéoplasiques (usage thérapeutique)</term>
<term>Association thérapeutique</term>
<term>Diagnostic différentiel</term>
<term>Humains</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Octréotide (usage thérapeutique)</term>
<term>Récidive tumorale locale ()</term>
<term>Soins palliatifs</term>
<term>Sélénium (usage thérapeutique)</term>
<term>Techniques de physiothérapie</term>
<term>Tumeurs de l'oropharynx ()</term>
<term>Tumeurs oto-rhino-laryngologiques ()</term>
<term>Évolution de la maladie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents</term>
<term>Octreotide</term>
<term>Selenium</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
<term>Neoplasm Recurrence, Local</term>
<term>Oropharyngeal Neoplasms</term>
<term>Otorhinolaryngologic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques</term>
<term>Octréotide</term>
<term>Sélénium</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term>
<term>Diagnosis, Differential</term>
<term>Disease Progression</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Palliative Care</term>
<term>Physical Therapy Modalities</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Diagnostic différentiel</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Mâle</term>
<term>Récidive tumorale locale</term>
<term>Soins palliatifs</term>
<term>Techniques de physiothérapie</term>
<term>Tumeurs de l'oropharynx</term>
<term>Tumeurs oto-rhino-laryngologiques</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The occurrence of edema is a serious problem of patients suffering from cancer and may have various causes. Particularly, the secondary malignant lymphedema poses a special threat to patients. In some cases, it indicates the progression of illness, and in fact also results in mutilating physical changes, which add to the already existing impairments caused by the cancer disease. So far therapeutic interventions are limited. Current management consists of physical therapy and pharmacological interventions. There are few powerful studies concerning the efficiency and hardly any concerning combined or comparative treatment in the literature. Most of them focus on the management of lymphedema in breast cancer patients. Preventive measures and supportive therapy are rarely being discussed. In this case report, we describe the successful use of Selen and Sandostatin in treating a facial edema of a patient with advanced head-neck cancer.</div>
</front>
</TEI>
<affiliations><list><country><li>Autriche</li>
</country>
<region><li>Vienne (Autriche)</li>
</region>
<settlement><li>Vienne (Autriche)</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Doller, Walter" sort="Doller, Walter" uniqKey="Doller W" first="Walter" last="Döller">Walter Döller</name>
</noCountry>
<country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Hammerl, Bernhard" sort="Hammerl, Bernhard" uniqKey="Hammerl B" first="Bernhard" last="Hammerl">Bernhard Hammerl</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006830 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006830 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:19165449 |texte= [Secondary malignant lymphedema in head and neck tumors]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19165449" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |